Background: To assess the safety and efficacy of Trans-obturator tape (TVT-O) for female stress urinary incontinence (SUI). Methods: A cohort of 35 cases of SUI and underwent TVT-O procedure over a period of 4 years. Pre-operative evaluation included pelvic examination, one hour pad test, urodynamic study, urinary diary and baseline haematological tests. Post-operatively all women had post-void residual volume and were followed up for 3 years. Results: The mean age of the patients was 47±9.5 years. TVT-O alone was done in 58.1% of cases. 41.9% of cases had TVT-O done as a concomitant procedure. The median duration of follow-up was 48 months. The overall objective and subjective cure rate was 92.3% with failure rate of 7.7%, 12.9% of women reported post-operative thigh pain and 6.5% patients had immediate post-operative urinary retention. 16.1% of the patients had post-operative voiding dysfunction. No major complications were encountered in these patients. Conclusions: TVT-O is a safe, easy and effective minimally invasive procedure for female SUI with minimal acceptable complications.
INTRODUCTION
SUI is a self-limiting distressing condition affecting many women. As defined by the International Conference Society (ICS), it is involuntary leakage of urine with increased intra-abdominal pressure without rise in detrusor pressure. 1 This condition is not life threatening but has a negative social, psychological impact on the quality of life. The surgical management of SUI has revolutionized over the last 2 decades because of better understanding of the pathophysiology of SUI. Based on the Integral theory, continence can be achieved by placing a tension free tape underneath the mid-urethra. The mid-urethral tape acts as a neo-pubourethral ligament which supports the urethra to maintain continence. 2 The cure rate of SUI with TVT reported in published series is 81%. 3 However, this procedure is not without complications. The described complications are bladder perforation, bowel and major vessel injury. Post-operative voiding dysfunction, denovo urgency and urinary incontinence 4, 5 appear to be the complications related to the blind retropubic passage of the trochar. 6, 7 In an attempt to reduce the morbidity of retrograde needle passage, an alternative approach is the trans-obturator tape. With the trans-obturator approach the vaginal tape was placed in between the obturator foramen. The technique followed is the outside-in technique described by Detrome in 2001 and the inside-out technique described by De Leval in 2003. 8, 9 Trans-obturator tape is a tension-free sling which lies in the mid-urethra at a less acute angle compared to TVT. Thus, it is associated with less incidence of voiding dysfunction. This procedure permits a lower dissection, precise and reproducible insertion and there by lowers the incidence of injury to bowel and urethra. 10 The reported overall cure rate with TVT-O is 82% at 6 and 12 months and 90% at 24 months. 11 SUI is a common problem in Indian women. Earlier women suffered in silence. But with increasing life expectancy, education level and awareness women are seeking help to overcome this problem. The present study is to assess the safety and efficacy of TVT-O in women with SUI.
METHODS
35 patients with symptoms of SUI, attended the Gynaecology OPD at a tertiary referral centre were included in the study. These women were offered the TVT-O procedure (Gynaecare, Ethicon Inc., Somerville, NJ, USA). All the patients underwent a detailed urogynaecological history, pelvic examination, cough test, 1 hour pad test and urinary diary. Multichannel urodynamic study including uroflowmetry, filling and voiding cystometry and urethral pressure profile was carried out in 33 patients. Patients with both urethral hypermobility and intrinsic sphincter deficiency were offered TVT-O. Patients with overactive bladder or mixed urinary incontinence were excluded from this study.
TVT-O-inside out technique was done under spinal anaesthesia. General anaesthesia was reserved for patients who had TVT-O combined with other pelvic surgeries. Intra-operatively single dose of Inj. Cefazolin 1gm was administered.
Intra-operative date including operation time, blood loss and complications were recorded. Catheter was removed 12 hours post-operatively or delayed if TVT-O was done along with pelvic reconstructive surgeries. Post-void residue was checked in all patients. Post-void residual volume more than 150ml was considered to be high. Post-operative follow-up was scheduled to occur at 6 weeks after discharge and then half-yearly followed by yearly visits. During follow-up, patient had a pelvic examination and cough test. Symptoms of bladder dysfunction like urinary retention, denovo urgency, dysuria, thigh pain and sexual dysfunction were looked at. The objective and subjective cure rates were assessed at 6 each follow-up visits. Subjective cure rate was defined as those patients who reported no leakage of urine on physical activity and on the questionnaire of urogenital distress inventory. Those patients who had a negative cough stress test on clinical examination were labeled as objectively cured.
RESULTS
4 patients who underwent TVT-O alone are on follow-up now and hence not included in the analysis. The mean age of the patients was 47±9.5 years and the mean BMI was 26.5±4. 61.3% of these patients were postmenopausal (n=19) and 9.7% were on hormone replacement therapy (n=3).
TVT-O alone was performed in 58.1% of the patients (n=18). Remaining, 41.9% had the TVT-O as a concomitant procedure (n=13). In these 13 patients, 9.7% had vaginal hysterectomy and a pelvic floor repair (n=3), 19.4% had a cystocoele repair (n=6), 3.2% had a laparoscopic assisted vaginal hysterectomy (n=1), 3.2% had a Fothergill's repair (n=1) and 6.5% had laparoscopic sterilization (n=2) ( Table 1) . 15 Concomitant vaginal surgery does not alter the long-term results of TVT-O or cause post-operative voiding dysfunction. 16 The reported incidence of postoperative urinary retention in a study by Jose et. al. was 7.9% 11 which is similar to what has been found in this study 6.5%. The mean duration of the procedure was 30±8 minutes in patients who underwent TVT-O alone. One advantage of TVT-O is that the retro pubic space is avoided thereby reducing the incidence of bladder perforation. Hence, cystoscopy is not necessary to look for bladder perforation in TVT-O as against TVT where there is increased risk of bladder perforation. This decreases the overall procedural time with TVT-O.Postoperative voiding dysfunction reported with TVT-O is 2-13%. 17, 18 In this study voiding difficulty occurred in 5 patients -4 of them had DE novo urgency and 1 patient developed urinary tract infection. One patient who developed DE novo urgency had a concomitant cystocele repair. The reported rate of urinary retention following the procedure varies between 1.5-13%. 19, 20 Of the 2 patients in this study who had postoperative urinary retention one resolved spontaneously after 48 hours of catheterization. However, one patient had urinary retention after removing catheter and was on clean intermittent self-catheterization for 4 weeks, following which she voided freely. The lower incidence of urgency and urinary incontinence was because of preservation of the periurethral fibers as the retro pubic space is not entered and secondly, the sling is less obstructive as it is placed below the mid-urethra like a hammock. 5-20% of patients may experience management failure resulting in recurrent or persistent SUI. [21] [22] [23] Repeat anti-incontinent surgeries are usually associated with a higher failure rate probably due to scarring, altered anatomy, fibrosis, urethral obstruction and intrinsic sphincter deficiency. Patients with failed primary anti-incontinent procedure have a high incidence of intrinsic sphincter deficiency than the primary procedure (31% versus 13%, p<0.001). The subjective cure rate was 86% and 62% in primary and repeat group respectively (p<0.001). 24 The retro pubic procedure has a significantly high success rate than repeat TVT-O (71% versus 48%) in patients with recurrent stress urinary incontinence. However, in this study 4 patients with previously failed anti-incontinent procedures (2 previous TVT-O and 2 previous TVT) underwent repeat trans-obturator repair with complete cure during follow up. Tape erosion rate with macro porous monofilament mesh ranges between 0-2.7%. [25] [26] [27] None of the patients in this study had erosion of tape so far. Bladder perforation usually encountered is around 5.4%. 28 In this study none of the patients had bladder perforation. One of the complications unique to TVT-O is the potential damage to the contents of obturator foramen, adductor compartment abscess, transient inner thigh pain, lower extremity pain, neuropathic pain and difficulty in ambulation. 29, 30 In this series 4 patients developed neuropathic pain and pain in the inner aspect of the thigh which resolved with anti-inflammatory analgesics.
CONCLUSION
To conclude the results of TVT-O are safe and encouraging. The procedure is an effective and minimally invasive surgery with satisfactory subjective and objective cure rates during 3 years' follow-up. It is equally safe and effective when done concomitantly with other pelvic surgeries. However, larger number of patients needs to be followed up to come to a robust conclusion regarding its long-term safety and efficacy.
